Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Concerns about Ozempic's market status have sparked uncertainty among patients relying on GLP-1 therapy for weight management. The FDA has not removed semaglutide from the market, though supply fluctuations and manufacturing delays have created access challenges. PlexusDx provides a stable, affordable alternative through compounded semaglutide injections, giving you treatment continuity without the supply unpredictability of brand-name medications.

Understanding Ozempic's Current Status and Market Availability

Ozempic remains available in the United States through standard pharmacy channels, though temporary shortages have occurred due to manufacturing adjustments and increased demand from both diabetes and weight loss applications. The FDA has not discontinued semaglutide, and the brand continues production to meet patient needs. However, insurance restrictions, prior authorization requirements, and supply delays create real barriers for many people seeking this therapy.

The confusion about Ozempic's availability stems partly from tirzepatide (Mounjaro/Zepbound) entering the market as a competing GLP-1 receptor agonist. Both medications work through similar mechanisms but have different manufacturing pathways, leading to separate supply dynamics. Understanding that brand-name medications are just one option helps patients recognize that losing access to Ozempic does not mean losing access to semaglutide therapy itself.

Why Compounded Semaglutide Offers Greater Stability Than Brand-Name Alternatives

Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as Ozempic but is manufactured through a different regulatory pathway that reduces supply chain vulnerability. PlexusDx partners exclusively with 503A compounding facilities—not 503B—which operate under stricter quality controls and state pharmacy board oversight. This model means you're not dependent on a single manufacturer's production capacity or corporate decisions about market positioning.

Because compounded medications are prepared in individual batches, your prescription doesn't compete with insurance coverage disputes, hospital purchasing agreements, or mass-market allocation decisions. Your dose may need to go up as your body responds to treatment, but your price won't change—a cost stability that brand-name therapies cannot guarantee as insurance formularies and copay tiers shift throughout the year.

How PlexusDx Semaglutide Injections Fit Into Your Weight Loss Plan

PlexusDx semaglutide injections start at $149 per month, with no insurance requirement, no membership fees, and HSA/FSA eligibility built in. The medication works by slowing stomach emptying, increasing feelings of fullness, and signaling your brain that you've eaten enough—the same mechanism that makes Ozempic effective for weight management. Weekly self-administered injections fit into a standard routine, and dose adjustments happen gradually over weeks to minimize side effects while maximizing results.

Patients using PlexusDx therapy have access to our licensed compounding network across all 50 states, meaning geographic location, state regulations, or pharmacy network restrictions don't block your treatment path. Your prescription is prepared specifically for you, starting at the lowest effective dose and only increasing based on your individual response and tolerance—not based on insurance tier or availability constraints.

Personalization Through Genetic Testing Improves Your Outcomes

PlexusDx offers the Precision Peptide Genetic Test (a $99 add-on after your first month) to identify how your unique genetic profile influences your response to GLP-1 therapy. This test analyzes key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—markers that shape how your body processes appetite signaling and metabolic regulation. Understanding these pathways allows PlexusDx to map your results across 14 metabolic pathways, 49 peptides, and 150+ genetic insights specific to weight loss response.

Genetic testing doesn't replace clinical judgment, but it does explain why some patients respond dramatically to GLP-1 therapy while others require dose adjustments or dual-compound protocols. This precision approach means you're not just taking semaglutide—you're taking the right dose at the right concentration based on your genetic predispositions, not trial-and-error dosing that wastes time and money.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Ozempic actually being discontinued or taken off the market?

No. The FDA has not removed semaglutide from the market, and Ozempic remains available through pharmacies. Supply disruptions and insurance barriers have created access challenges, but the medication itself is not being discontinued. PlexusDx semaglutide injections offer a stable alternative that doesn't depend on brand-name availability or insurance approval.

How is compounded semaglutide different from Ozempic in terms of safety and effectiveness?

Compounded semaglutide contains the identical active pharmaceutical ingredient as Ozempic and works through the same GLP-1 receptor mechanism. PlexusDx uses licensed 503A compounding pharmacies (not 503B), which maintain rigorous quality standards. The primary differences are cost, supply stability, and the ability to start at lower doses without insurance interference.

Why does PlexusDx pricing stay flat while my dose increases?

PlexusDx charges a monthly flat rate ($149 for semaglutide injection) regardless of your dose level—whether you're at 0.25 mg, 0.5 mg, 1 mg, or 2.4 mg weekly. This model removes the financial penalty for dose escalation, letting your body find its optimal dose without worrying that each increase will raise your monthly cost.

What side effects should I expect when starting semaglutide, and how are they managed?

Most common side effects include mild nausea, vomiting, constipation, and fatigue during the first 2–4 weeks. PlexusDx uses a gradual dose escalation protocol to minimize these effects; starting low allows your body to adapt. Staying hydrated, eating smaller meals, and taking time before meals all help manage nausea. Serious side effects are rare but require immediate medical attention.

Can the Precision Peptide Genetic Test help me predict how well semaglutide will work?

Yes. The test identifies your genetic variants in appetite and metabolism pathways (GIPR, GLP1R, FTO, MC4R), which influence how strongly you respond to GLP-1 therapy. PlexusDx maps these results across 14 pathways and 150+ insights, helping your prescriber anticipate your dose needs and whether you might benefit from dual-compound therapy like GLP-Squared instead.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves